Molecular Diagnostics
News on lab-developed tests and emerging diagnostic technologies.
Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent
The Abbott Park, Illinois-based firm's global COVID-19-related sales were $2.3 billion in the fourth quarter, including $2.1 billion from rapid testing.
Molecular Diagnostics Firm Mainz Biomed Prices $22.5M Follow-on Share Offering
In the first half of this year, the firm intends to launch a clinical study and begin the submission process to obtain FDA clearance for its colorectal cancer diagnostic test.
Dante Labs to Refund COVID-19 Test Customers Following UK Regulatory Investigation
The move comes as the UK's Competition and Markets Authority cracks down on PCR test providers for price gouging and other improper business practices.
ESHG Calls Use of Polygenic Risk Scores in Preimplantation Testing Unethical
Despite being marketed by private companies, preimplantation genetic testing using polygenic risk scores remains premature, ESHG representatives wrote in a recent paper.
AnPac Bio Warned by Nasdaq Over Listing Requirement
The company has until July 18 to meet Nasdaq compliance by getting its market value of publicly held shares to at least $15 million.